DataMEDS AI, Inc. (MEDS)
NASDAQ: MEDS · Real-Time Price · USD
2.030
+1.165 (134.60%)
Sep 15, 2026, 2:49 PM EDT - Market open
DataMEDS AI Revenue
DataMEDS AI had revenue of $1.78M in the quarter ending June 30, 2026, a decrease of -77.15%. This brings the company's revenue in the last twelve months to $8.02M, down -78.16% year-over-year. In the year 2025, DataMEDS AI had annual revenue of $23.34M with 28.73% growth.
Revenue (ttm)
$8.02M
Revenue Growth
-78.16%
P/S Ratio
0.33
Revenue / Employee
n/a
Employees
n/a
Market Cap
6.22M
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 23.34M | 5.21M | 28.73% |
| Dec 31, 2024 | 18.13M | - | - |
| Dec 31, 2023 | - | - | - |
| Dec 31, 2022 | - | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
MEDS News
- 11 minutes ago - Why Is DataMeds AI Stock (MEDS) Up Nearly 200% Today? - TipRanks
- 5 hours ago - Axe Compute sells Helomics to DataMEDS AI, terms undisclosed - TheFly
- 7 days ago - Datameds, AI., and Tollo Health Partner with the NFL Alumni Association for Health Lives Here National Campaign Rollout - Accesswire
- 19 days ago - DataMeds AI and Tollo Health Announce Fall 2026 Cold & Flu #Back2School50% Marketing Campaign for Viral Infections Medical Food Galectovid(TM) - Accesswire
- 4 weeks ago - DataMEDS AI reports Q2 EPS ($7.13) vs. ($5.40) last year - TheFly
- 4 weeks ago - DataMeds AI Reports Second Quarter 2026 Financials and Provides Business Update - Accesswire
- 4 weeks ago - DataMEDS AI provides update on Corexa Pharmacy - TheFly
- 4 weeks ago - DataMEDS AI Announces Its Board of Directors Approved September 9, 2026 as the Payment Date of the Previously Announced Distribution of Dream Bowl Meme Coin I Tokens to Record Holders of Common Stock and other Eligible Equity Securities as of the Record Date of August 7, 2026 - Accesswire